Verve Therapeutics Inc (VERV)
4.85
+0.25
(+5.43%)
USD |
NASDAQ |
Nov 22, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Profit Margin (Quarterly): -730.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -730.3% |
| June 30, 2024 | -744.2% |
| March 31, 2024 | -855.8% |
| December 31, 2023 | -940.0% |
| September 30, 2023 | -1.47K% |
| Date | Value |
|---|---|
| June 30, 2023 | -2.58K% |
| March 31, 2023 | -3.70K% |
| December 31, 2022 | -4.06K% |
| September 30, 2022 | -4.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.86K%
Minimum
Sep 2022
-730.3%
Maximum
Sep 2024
-2.22K%
Average
-1.47K%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Ardelyx Inc | -0.82% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Sage Therapeutics Inc | -788.1% |
| ALX Oncology Holdings Inc | -- |
| Immuneering Corp | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.52% |
| Return on Assets | -28.45% |
| Return on Invested Capital | -36.52% |
| Operating Margin (Quarterly) | -829.0% |
| Return on Net Operating Assets | -181.7% |